Back
ESC Professional Premium Access

Antithrombotic therapy in TAVI patients without indication for oral anticoagulation.

Session: What you need to know about antithrombotic therapy in patients after TAVI
Topic: Clinical
Speaker: Professor G. Dangas (New York, US)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Professor George Dangas

Mount Sinai Medical Center, New York (United States of America)
18 presentations
0 follower

4 more presentations in this session

Embolic stroke. Ischaemic and bleeding risk in patients undergoing TAVI.

Speaker: Professor D. Capodanno (Catania, IT)

Access
Slides
Video
Thumbnail

Antithrombotic therapy in TAVI patients with indication for oral anticoagulation.

Speaker: Professor M. Valgimigli (Lugano, CH)

Access
Slides
Video
Thumbnail

Antithrombotic therapy during TAVI and peri-interventional management of antithrombotic therapy.

Speaker: Doctor M. Joner (Munich, DE)

Access
Slides
Video
Thumbnail

What you need to know about antithrombotic therapy in patients after TAVI – discussion.

Access
Video
Thumbnail

Access the full session

What you need to know about antithrombotic therapy in patients after TAVI

Speakers: Professor G. Dangas, Professor D. Capodanno, Professor M. Valgimigli, Doctor M. Joner
Access
Video
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb